Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma
Completed · Phase 2
Conditions studied: Esophageal Cancer
In brief
Surgery (esophagectomy or removal of the esophagus)has been the standard treatment for cancer of the esophagus. However, evidence suggests that preoperative chemotherapy and radiation therapy may add benefit. The purpose of this study is to determine if a treatment program of combined chemotherapy and radiation therapy prior to surgery and chemotherapy after surgery will delay or eliminate recurrence of the cancer.
Key facts
- Study ID
- NCT00230451
- Run by
- University of Michigan Rogel Cancer Center
- Starts
- 1997-11-01
- Expected to finish
- 2008-07-01
- Last updated by the study team
- 2010-01-15
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may not qualify if…
- Patients with active infection, pregnancy, lactating females, serious inter-current medical conditions including congestive heart failure, cardiac arrhythmias, or symptomatic coronary artery diseases are ineligible.
- No prior treatment allowed. No prior thoracic radiation.
Where it is running
- University of Michigan Cancer Center — Ann Arbor, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.